S
ingle cells represent the fundamental unit of biology; however, the vast majority of biological knowledge has emerged as a consequence of studying cell populations and not individual cells. Inevitably, there are fundamental and applied questions, such as those relating to transcriptional control of stem cell differentiation, intrinsic noise in gene expression, and the origins of disease, that can be addressed only at the single-cell level. For example, single-cell analysis allows for the direct measurement of gene expression kinetics, or for the unambiguous identification of coregulated genes, even in the presence of desynchronization and heterogeneity that could obscure population-averaged measurements. Similarly, single-cell methods are vital in stem cell research and cancer biology, where isolated populations of primary cells are heterogeneous due to limitations in purification protocols, and it is often a minority cell population that is the most relevant. High-throughput single-cell measurement technologies are therefore of intense interest and have broad application in clinical and research settings.
Existing methods for measuring transcript levels in single cells include RT-qPCR (1), single molecule counting using digital PCR (2) or hybridization probes (3, 4) , and next generation sequencing (5) . Of these, single-cell RT-qPCR provides combined advantages of sensitivity, specificity, and dynamic range, but is limited by low throughput, high reagent cost, and difficulties in accurately measuring low abundance transcripts (6) .
Microfluidic systems provide numerous advantages for singlecell analysis: economies of scale, parallelization and automation, and increased sensitivity and precision that comes from small volume reactions. Considerable effort over the last decade has been directed toward developing integrated and scalable singlecell genetic analysis on chip (7, 8) . Thus, many of the basic functionalities for microfluidic single-cell gene expression analysis have been demonstrated in isolation, including cell manipulation and trapping (9, 10), RNA purification and cDNA synthesis (11) (12) (13) , and microfluidic qPCR (14) following off-chip cell isolation, cDNA synthesis, and preamplification. In particular, microfluidic qPCR devices (Biomark Dynamic Array, Fluidigm) have recently been applied to single-cell studies (15, 16) . Although these systems provide a high-throughput qPCR readout, they do not address the front end sample preparation and require single-cell isolation by FACS or micropipette followed by off-chip processing and preamplification of starting template prior to analysis. The critical step of integrating all steps of singlecell analysis into a robust system capable of performing measurements on large numbers of cells has yet to be reported. A single demonstration of an integrated device for directly measuring gene expression in single cells was described by Toriello et al., combining all steps of RNA capture, PCR amplification, and end-point detection of amplicons using integrated capillary electrophoresis (17) . Despite the engineering complexity of this system, throughput was limited to four cells per run, cell capture required metabolic labeling of the cells, and the analysis was not quantitative. Thus, there remains an unmet need for microfluidic technologies capable of scalable and quantitative single-cell genetic analysis.
Here we describe an integrated microfluidic device for highthroughput RT-qPCR analysis of mRNA and miRNA expression at a throughput of hundreds of single cells per experiment. We show that this technology provides a powerful tool for scalable single-cell gene expression measurements with improved performance, reduced cost, and higher sensitivity as compared to analysis in microliter volumes. This technology represents the implementation of robust and high-throughput single-cell processing and amplification of nucleic acids on a chip, thereby achieving a major milestone in microfluidic biological analysis.
Results and Discussion
Device Design. An integrated microfluidic device that performs 300 parallel RT-qPCR assays and executes all steps of single-cell capture, lysis, reverse transcription, and qPCR is shown in Fig. 1A .
To facilitate the precise comparison of different samples and cell types, our prototype consists of six independent sample-loading lanes, each containing 50 cell-processing units. We resolved previously limiting technical pitfalls by the inclusion of design elements to (i) allow for efficient distribution of single cells without mechanical damage, (ii) minimize background signal arising from free RNA or cell debris in the medium, and (iii) avoid reaction inhibition by cell lysates in nanoliter volumes.
In order to reduce device complexity and obviate the need for RNA purification, we optimized our device to be compatible with commercially available assays that use "one-pot" RT-qPCR protocols requiring only the sequential addition of reagents into a single reaction vessel. Each cell-processing unit consists of a compound chamber, formed by a cell capture chamber connected sequentially to two larger chambers for RT and qPCR (Fig. 1B) . This simple fluidic architecture allows the implementation of either heat lysis followed by two-step RT-qPCR ( Fig. 1 D-I ), or chemical lysis followed by one-step RT-qPCR. A detailed description of device operation for each of these protocols is provided in SI Materials and Methods. All lanes are connected to a common feed channel that, following the completion of each reaction step, is used to inject the next reaction master mix through the upstream chambers, thereby diluting the intermediate product (cell lysate or cDNA) and assembling the next reaction mixture. This parallelization of reaction assembly in a microfluidic format ensures equal timing of all reaction steps and greatly reduces technical variability associated with pipetting and mixing steps in microliter volumes. Fluorescence measurements were performed to ensure the efficient and reproducible transfer of reactants at each step, showing that losses in sample transfer are below 5%. To minimize device expense and complexity, temperature control and fluorescence detection were performed using peripheral hardware including a CCD detector mounted above a flatbed thermocycler plate.
We designed our chamber volumes to ensure sufficient dilution between each processing step to avoid reaction inhibition while at the same time maintaining high template concentrations and assay sensitivity. Initial attempts to perform RT-qPCR in low nanoliter volumes were found to produce highly variable results, including nonspecific amplification and inconsistent detection of abundant transcripts (18) . Cell lysate dilutions showed that reaction inhibition becomes significant at concentrations in excess of 0.2 cells∕nL, or 10 cells∕50 nL-reaction (Fig. 2D) . On the other hand, RT-qPCR measurement noise has been shown to become the dominant source of variability when starting at concentrations below one copy per 100 nL (6) , illustrating that minimizing reaction volumes is critical for precise measurements on limited template. Finally, experiments in tubes were performed to determine that a dilution ratio of at least 5∶1 (PCR mix∶RT product) is optimum for PCR efficiency. We therefore designed our combined reactors to have an aggregate total volume of 60.6 nL, consisting of a 0.6-nL cell capture chamber, a 10-nL RTchamber, and a 50-nL qPCR chamber. These volumes allow for the reliable amplification of single molecules ( Fig. 2A ) and result in a final template concentration of 330 ng∕mL when starting from a single-cell equivalent of RNA (20 pg) . The use of larger volume RTand PCR chambers has the added advantage of reducing their surface-to-volume ratio, thereby minimizing reagent evaporation through the gas permeable device material (polydimethylsiloxane).
Another critical step toward integration was to efficiently distribute single cells into each location on the array without mechanical damage. To achieve reproducible and deterministic loading of single cells into each array element, we engineered a hydrodynamic single-cell trap within each capture chamber. Cell traps consisting of a single cup structure (19) were found to be highly inefficient, capturing less than 0.1% of cells passing in close proximity to the center of the channel structure. To improve capture efficiency, we incorporated upstream deflectors, located 22.5 μm from the trap, to focus cells into the central streamlines where capture is most efficient (Fig. 1C) . Using these structures we were able to achieve high single-cell occupancy of array locations (Fig. 3 A and B) . Over eight separate experiments, a loading protocol of approximately 60 s (10 6 cells∕mL, 20 nL∕s per lane) resulted in the successful isolation of single cells in 1;518∕1;700 chambers (89.3%), with a cell capture efficiency of 5.0 AE 0.5%. Staining with trypan blue was used to assess the viability of cells after loading and was determined to be equivalent to the viability of the input sample (97.4% viability vs. input 96.8%). Finally, measurements of the distribution of cell diameters prior to and after loading indicated that cell trapping did not introduce significant bias (p ¼ 0.67, two-sample t test) in selecting cells of different sizes (Fig. S1 ). This cell trap geometry and loading protocol were used in all subsequent qPCR measurements presented below. Further improvement of trap and deflector geometries were found to achieve fill factors of >99% (100 single cells captured out of 100 traps analyzed) and cell capture efficiencies of 87.0 AE 4.5%, with cell viability again matching the input sample (>98%) and not significantly biasing cell sizes (p ¼ 0.35, twosample t test), making this method applicable to the analysis of limited quantity samples such as rare stem cells or clinical samples.
The immobilization of cells in traps was also used for on-chip washing of cells prior to lysis to remove free RNA, cellular debris, and untrapped cells that would otherwise give rise to background signal or result in low single-cell occupancy (Fig. S2 A and B) . The efficiency of chamber washing, determined by loading purified RNA template (36.5 ng∕μL), followed by washing and RT-qPCR analysis, was >99.99% (1.1 × 10 4 copies measured without wash, 0 copies detected after washing) (Fig. S2C ). In addition, RT-qPCR measurements testing different cell loading and washing protocols demonstrated that on-chip washing allows for loading directly from culture medium with low background as compared to off-chip wash steps followed by analysis in microliter volumes (Fig. 2C) . Importantly, on-chip washing allows for lysis within seconds of washing, thereby minimizing spurious transcriptional responses that may arise from sequential medium exchange and spin steps.
Validation of Integrated Single-Cell RT-qPCR. We first tested the sensitivity and precision of RT-qPCR in our device by performing measurements of GAPDH expression over an 8-fold dilution series of total RNA, ranging from 40 pg (approximately 2 cell equivalents) to 10 fg (approximately 1∕2;000 cell equivalents). RNA was purified from K562 cells, a BCR-ABL positive human cell line derived from a patient with chronic myeloid leukemia (20) (Fig. 2 A-C) . The efficiency of amplification was determined over the four highest template concentrations (40 pg, 5 pg, 625 fg, and 78.125 fg) as the slope from a linear least squares fit of log 2 ðCÞ vs. cycle threshold (CT) and was found to be 0.988 AE 0.055. The standard deviation of CT values was less than 0.15 at the three highest concentrations (SD ¼ 0.08, 0.10, and 0.14 for the 40 pg, 5 pg, and 625 fg samples, respectively), indicating uniform amplification across the array and technical error of less than 10% in absolute concentration, near the limit of qPCR precision. The highest measurement variability was observed in the 78-fg sample, where shot noise (Poisson sampling noise) is most pronounced and accounts for approximately 50% of the measurement variance. Template amounts below 625 fg resulted in a digital pattern characteristic of single molecule amplification (49∕50 for 78 fg and 19∕50 for 10 fg) and consistent with the expected occupancy of chambers as determined by a binomial distribution (2) . Based on the frequency of single molecule detection in the 10-fg sample, we measured the average copy number of GAPDH to be 979 AE 240 transcript copies per single-cell equivalent (20 pg) (Fig. 2 ). This measurement is comparable to previous reports (11) and is in close agreement with an independent estimate based on normalizing the dilution series to CT values obtained for single molecules (copies∕20 pg ¼ 1∕2 × copies∕40 pg ¼ 1∕2 × ð1þ efficiencyÞ ðCTð40 pgÞ−CTðsingle moleculeÞÞ ¼ 1;407 AE 153 copies∕ 20 pg). It should be noted that these estimates represent a lower bound because they do not account for RT efficiency; the RT efficiency of GAPDH has been previously estimated to be approximately 50% (13) but is dependent on transcript secondary structure and assay design. A comparison of CT values obtained from on-chip qPCR from cDNA synthesized off-chip demonstrated that on-chip RT efficiency is equal to that obtained off-chip when working from the same RNA concentrations (Fig. S3) . Finally, comparison of the same dilution series of RNA, assayed for GAPDH both on-chip and in tubes (20-μL volume) (Fig. 2C) , showed that on-chip analysis provides improved sensitivity.
We next evaluated the efficiency and reliability of on-chip cell processing by comparing our GAPDH measurements of purified RNA to measurements performed directly from single K562 cells (Figs. 2C and 3C). K562 cells were loaded directly from culture medium followed by washing and analysis using a chemical lysis and one-step RT-qPCR protocol (Cells Direct™, Invitrogen). Using a CT threshold of 31.5, corresponding to the mean CT of a single molecule of GAPDH (CT ¼ 30.5) plus two standard deviations (SD ¼ 0.5), we observed successful amplification in 100% of single cells (N ¼ 233) (Fig. 3 A and B) . Adjacent chambers that did not contain a cell were clearly separated from singlecell measurements with an average Δ CT value of 5.7 (five empty chambers, three of which amplified) ( (Fig. 3C ). These expression levels are consistent with previous estimates in single cells (11) . Additionally, the mean CT of 20.3 observed for single cells matches measurements of single-cell equivalent lysate (CT ¼ 20.2, Fig. 2D ). Using digital PCR on cDNA prepared from K562 cell lysate, we measured an average of 1;229 AE 72 GAPDH molecules per single-cell equivalent. We conclude that the relative efficiency of on-chip single-cell lysis and mRNA extraction/accessibility is equal to that achieved when working from RNA purified from large numbers of cells. Finally, as expected, RT-qPCR measurements from chambers loaded with more than one cell show reduced variability and lower CT values (Figs. S2A and S5). Taken together, these results establish the precise measurement of mRNA abundance with single molecule sensitivity and the dynamic range needed for single-cell analysis.
Application to Measurement of Single-Cell miRNA Expression. We next applied our technology to the study of single-cell miRNA expression. miRNAs are thought to provide a unique signature of cellular state and are central players in orchestrating development and oncogenesis, making them a promising class of biomarker for single-cell analysis (15, 22, 23) . Importantly, the short length of miRNAs (approximately 22 nucleotides) makes them difficult to detect by hybridization approaches, so that RT-qPCR is the dominant quantification strategy. To demonstrate the robustness and throughput of our technology, we performed a total of 1,672 single-cell measurements to examine single-cell variability in the expression of nine miRNAs spanning a wide range of abundance (>16;000 copies per cell to <0.2 average copies per cell). K562 cells were again chosen as a heterogeneous population for this study because they are known to exhibit mixed characteristics of erythrocytes, granulocytes, and monocytes (20, 24) . We first measured the expression of miR-16, a highly expressed micro-RNA that is found in many tissue types (25) and has been suggested as a suitable internal standard for normalization (26) . We found that miR-16 was log-normally distributed across K562 cells, but with slightly lower expression and notably tighter regulation than GAPDH, having an average of 804 (SD ¼ 261) copies per cell and a standard deviation of 30% (mean CT ¼ 21.4, SD ¼ 0.4). This strikingly low variability is within our estimates of cell volume differences (Fig. S1) . Matched experiments on single cells, isolated by micropipette into 20-μL volume tubes displayed an increase in measurement variability to approximately 90% (mean CT ¼ 29.5, SD ¼ 0.9), demonstrating the improved precision of parallel microfluidic cell processing in nanoliter volumes (Fig. 4A) . Microliter volume experiments also showed a pronounced increase in measured CT values that results from the low concentration of template and the large number of required PCR cycles.
To demonstrate the utility of our device for measuring differential expression in single cells, we next measured the expression of miR-223, a miRNA implicated in myeloid differentiation (24, 27) . In contrast to miR-16, K562 cell miR-223 expression was found to be highly variable (mean CT ¼ 22.2, SD ¼ 1.6, copy number ¼ 513, SD ¼ 406) and was not log-normally distributed (Fig. 4B) , consistent with the known functional heterogeneity of K562 cells. These measurements highlight the utility of single-cell miRNA expression analysis for assessing the heterogeneity of cell populations and for identifying miRNAs that are useful biomarkers of cellular state. To further explore this possibility, we measured the expression of an additional seven miRNAs (nine total) and plotted the patterns of singlecell expression in K562 populations (Fig. 4C ). Following the procedure described above, we used single molecule CT values, obtained by digital PCR, to translate measured CT values to absolute copy number. Assuming 100% efficient amplification, we observed that the copy number, calculated as 2 ðCTðsingle cellÞ−CTðsingle moleculeÞÞ , was well correlated (coefficient of 0.9932) with the average copy number obtained by digital PCR of cDNA prepared from bulk lysates (Fig. 4D ). Single-cell measurements revealed distinct patterns of miRNA expression, with miR-16, miR-92, and miR-17-5p each exhibiting unimodal and tightly regulated distributions, whereas miR-223, miR-196a, and miR-145 showed multimodal distributions and a high level of cellular heterogeneity. Notably, for the lowest abundance miR-NA, miR-200a, we detected expression in only a small fraction of cells and at levels below approximately five copies per cell. The average miR-200a copy number over all cells was within a factor of two of that obtained by digital PCR (0.2 copies per cell). In contrast, miR-92 was found to be the most abundant miRNA and was present at approximately 16,000 copies per cell. These measurements established miRNA quantification in single cells with a dynamic range of greater than 10 4 and at single molecule sensitivity.
Finally, to illustrate the utility of single-cell measurements in precisely assessing differences in both the average expression and the heterogeneity between two different cell populations, the expression levels of miR-16 and miR-223 in K562 cells were compared to those in CA1S cells (28, 29) , a human embryonic stem cell line (hESC). Although miR-16 was found to be expressed in hESC at similar levels to K562 (ΔCT ¼ 0.6), we observed approximately a twofold greater variability in expression (mean CT ¼ 22.0, SD ¼ 0.7) (Fig. 4A) . In contrast, when compared to K562, single CA1S cell measurements of miR-223 showed strong down-regulation, with miR-223 detected in only 3.6% of cells. The absence of significant miR-223 expression in hESC is expected due to the role of miR-223 as a differentiation-specific miRNA (24, 27) .
Coregulation of miR-145 and OCT4 in Single Cells. The measurement of multiple transcripts in single cells allows for quantitative measurements of gene coregulation that would otherwise be masked by cellular heterogeneity (14) . To demonstrate this capability we designed an optically multiplexed assay to study the coregulation of miR-145 and OCT4, a known target of miR-145 (30) , during the differentiation of hESCs ( Table S1 ). Notably, single-cell analysis at day 6 showed a bimodal distribution in both OCT4 and miR-145, revealing a transition of cellular state (30) that likely reflects the spontaneous differentiation of a subpopulation of cells. The observed single-cell dynamics of miR-145 and OCT4 coregulation are not apparent in population measurements, highlighting the use of scalable single-cell transcriptional analysis in correlating molecular signatures to cellular decision making (14) .
Single Nucleotide Variant (SNV) Detection in Primary Cells. Finally, to establish the specificity of our method we used multiplexed measurements of mRNA SNVs to assess the genomic heterogeneity within a primary tumor sample. A total of 117 single cells isolated from a plural effusion of a metastatic breast cancer were assayed for the expression of a SNV mutant of the transcription factor SP1, previously identified by deep sequencing (31) (Fig. 5D ). Primers were designed using sequences flanking the SNV location and do not discriminate between the genomic DNA and mRNA transcript. Of the 117 primary cells analyzed, 22 (18.8%) were heterozygous for the mutant and wild-type allele, 85 (72.6%) were homozygous wild type, 1 (0.9%) was homozygous mutant, and the transcripts were undetected in 9 (7.7%). We did not detect the SP1 mutation in 37 control K562 cells and failed to detect the wild-type transcript in only 2 of these cells. In the absence of copy number alterations in the primary sample, these observed frequencies would suggest a mutant to wild-type SP1 ratio of 11.2% (18.8 × 1 þ 0.9 × 2 ¼ 20.6 mutant to 18.8 × 1 þ 72.6 × 2 ¼ 164 wild type). However, using digital PCR on purified DNA from the primary sample, we found the ratio of mutant to wild-type SP1 alleles to be 18.7 AE 2.3%, in agreement with the previously reported ratio of 21.9%, obtained by deep sequencing (31) . The lower frequency of cells expressing the mutant SP1 allele may be due to allelic expression bias or an amplification of the SP1 mutant allele, both of which are supported by Shah et al. (31) . Regardless, given that the frequency of tumor cells within the original sample was approximately 89% (31), both DNA molecule counting and single-cell RNA expression measurements show that the metastasis of this tumor is derived from multiple cancer cell lineages. 
Conclusion
Here we have demonstrated the implementation of scalable and quantitative single-cell gene expression measurements on an integrated microfluidic system. The presented device performs 300 high-precision single-cell RT-qPCR measurements per run, surpassing previous microfluidic systems by a factor of approximately 100 in throughput. Further scaling the throughput to over 1,000 measurements on a device with an area of one square inch is straightforward as each array element occupies an area of 0.6 mm 2 . In terms of performance, we have established a dynamic range of at least 10 4 , measurement precision of better than 10%, single molecule sensitivity, and specificity capable of discriminating the relative abundance of alleles differing by a single nucleotide. Compared to tube-based single-cell RT-qPCR, microfluidic processing provides improved reproducibility, precision, and sensitivity, all of which may be critical in identifying subtle differences in cell populations. Nanoliter volume also results in a 1,000-fold reduction in reagent consumption, thereby enabling costeffective analysis of large numbers of single cells. In over 3,300 single-cell experiments, using adherent and suspension cell lines as well as clinical samples, we have shown that microfluidic RT-qPCR is well-suited to the quantitative analysis of miRNA expression and SNV detection, both of which are difficult or inaccessible by alternative hybridization methods. Notably, our device allowed for precise comparison of the distributions of GAPDH and miR-16 expression. miR-16 was found to be exquisitely regulated in K562 cells, a finding that is striking given the known functional heterogeneity of this population and the high variability in the expression of other measured miRNAs. We postulate that higher variability of GAPDH expression reflects the fundamentally stochastic process of transcriptional bursts followed by mRNA degradation. Incorporation of miRNA into the RNA-induced silencing complex (RISC) is known to provide enhanced stability so that miRNA are inherently less subject to temporal fluctuations; miRNA are thus particularly suited as biomarkers for assessing single-cell state and population heterogeneity. We anticipate that scalable and precise single-cell miRNA analysis will become an invaluable tool in stratifying populations of mixed differentiation state (15) .
Here we have established the critical element of combining all single-cell-processing steps into an integrated platform. This functionality provides a solid foundation upon which increasingly advanced microfluidic single-cell transcription analysis may be built. We anticipate that more complex fluid routing (32) , to distribute cell contents across multiple chambers, will allow for the multiplexed measurements of tens of targets across hundreds of cells, and for combining this technology with single molecule detection by digital PCR. Alternatively, the microfluidic system described here could be used for single-cell processing and preamplification, with recovered reaction products analyzed by high-throughput microfluidic qPCR or sequencing. We contend that the simplicity of device operation will soon allow for the robust and automated implementation of single-cell RT-qPCR, leading to its widespread adoption in research applications and opening the prospect of diagnostic tests based on single-cell analysis.
Materials and Methods
Experimental details and protocols for device fabrication, device operation, on-chip and off-chip RT-qPCR, cell culture, hESC differentiation, digital PCR, mRNA-FISH, image analysis, transfer efficiency measurements, and cell trapping measurements are provided in SI Materials and Methods. (1, 2) . Planar silicon molds were defined by photolithography, using photomasks designed with CAD software (AutoCAD, Autodesk Inc.) and printed on transparency films at a resolution of 20,000 dots per inch (CAD/Art services). The "control" mold was fabricated using SU8-2025 photoresist (Microchem) to deposit valve features 24 μm in height. The "flow" mold was fabricated with three lithographic steps. First, the channels for reagent injection, and connections between chambers were fabricated using 13-μm high SPR220-7 photoresist (Shipley). The SPR220-7 channels were rounded to facilitate valve closure by incubation at 115°C for 15 min. A hard bake at 190°C for 2 h was used to prevent SPR photoresist erosion during addition of subsequent layers. Second, the cell trap features were defined in 14-μm SU8-2010 photoresist (Microchem). Finally, the large chambers and fluidic bus lines were constructed using 150-μm high SU8-100 photoresist. All photoresist processing was performed according to manufacturer specifications. All molds were fabricated on 4-inch silicon wafers (Silicon Quest International).
Microfluidic devices were cast from these molds in polydimethylsiloxane (PDMS, RTV615, General Electric). Each device consists of a three-layer elastomeric structure with a blank bottom layer, a middle control layer with channels that act as valves by pushing up and pinching closed channels in the above flow layer. The molds were first treated with chlorotrimethylsilane (TMCS, Aldrich) vapor for 2 min to prevent PDMS from bonding to the photoresist structures. The flow layer was made by pouring a mixture of PDMS (5 parts RTV615A∶1 part RTV615B) onto the flow mold, degassing, and then baking for 60 min at 80°C. A thin control layer was made by spin coating the control mold with PDMS (20 parts RTV615A∶1 part RTV615B) at 1,800 rpm and baking for 45 min at 80°C. After baking, the PDMS of the flow layer was peeled from the flow mold and aligned to the control layer. Following a 60-min bake at 80°C, the bonded two-layer structure was separated from the control mold, and channel access holes were punched. A blank layer (without channels) was prepared by spinning PDMS (20 parts RTV615A∶1 part RTV615B) on a blank wafer (2,000 rpm) and baking 45 min at 80°C. The bonded flow and control structure was mounted onto the blank layer and baked for 3 h at 80°C. Finally, the three-layer bonded structure was removed from the blank mold, diced into individual devices, and these were each bonded to clean glass slides by baking overnight at 80°C.
The device operation requires control of nine pneumatic valves and may be operated using a simple manifold of manual valves. For the current study a semiautomated implementation was used in which microfluidic valves were controlled by solenoid actuators (Fluidigm Corp.) controlled through a digital inputoutput card (NI-DAQ, DIO-32H, National Instruments) operated using LabView drivers (National Instruments). Tygon tubing connected the solenoids to the microfluidic device by 20-gauge stainless steel pins (Small Parts Inc.) fitted into the control line ports. Krytox (DuPont) oil was used as the fluid in the control lines, and the valves were actuated with 30-psi pressure.
Microfluidic Single-Cell RT-qPCR. The device was designed to be compatible with commercially available RT-qPCR products. A protocol for heat lysis, followed by a two-step RT-qPCR was used with miRNA and OCT4 mRNA assays. Alternatively, a chemical lysis, followed by one-step RT-qPCR, was used for mRNA measurements of single nucleotide variants (SNVs) and GAPDH.
Single-Cell Transcript Measurements by Heat Lysis and Two-Step RT-qPCR. The device was primed by flowing PBS containing 0.5 mg∕mL BSA and 0.5 U∕μL RNase inhibitor through all channels, while keeping the reverse transcription (RT) and PCR chambers empty and isolated by valves. The BSA helped prevent cells from adhering to channel walls. After priming, but prior to cell loading, all valves were closed. A single-cell suspension was injected into the device by applying pressure (approximately 2-3 psi) to microcapillary pipette tips plugged into the sample inlets. The sample inlets were first dead-end filled against an inlet valve to prevent air bubbles from entering the device. The sample inlet valves, cell chamber valves, and outlet valve were opened to allow the cell suspension to flow through the sample channels. Cells were loaded into the device suspended in culture media (directly from culture). Cell loading concentrations were kept between 5 × 10 5 and 1 × 10 6 cells∕mL, resulting in over 80% occupancy of cell traps with single cells in 1-2 min at a flow rate of approximately 20 nL∕s. Lower concentrations were found to require proportionately longer times to achieve high occupancy of trapped single cells. Concentrations greater than 2 × 10 6 cells∕mL were found to occasionally clog the inlet port or the channel at trap locations. A peristaltic pump was integrated into the device for controlling the flow rate; however, pressure-driven flow was used for the current study.
After injecting the cell suspension and trapping single cells the cell sample inlet valve was closed, and the cells were washed by flushing the line with the PBS solution. This removed untrapped single cells, extracellular RNA, and debris. Following on-chip washing, the cell chamber valves were closed to partition the cell loading channel and isolate individual cell reactors. Visual inspection of the cell-capture chambers under a microscope was used to confirm and count the number of cells in each chamber. The cells were lysed by placing the microfluidic device onto a flatbed thermocycler and heating it to 85°C for 7 min (and then cooled to 4°C).
RT was performed in the device by using the ABI High Capacity Reverse Transcription kit (3), with the addition of a surfactant to prevent adsorption of nucleic acids and proteins to PDMS surfaces (2 μL 10× Reverse Transcription Buffer, 4 μL 5× RT stem-loop miRNA primer from ABI, 1 μL 100 mM dNTPs, 1.34 μL of 50 U∕μL Multiscribe Reverse Transcriptase, 0.26 μL of 20 U∕μL RNase Inhibitor, 2 μL 1% Tween 20, 9.4 μL PCR grade water). The RT mix was loaded into the device and flushed through the reagent injection channels. RT reagent was injected into the reaction by opening the valve connecting the cell chamber to the RTchamber, and the valve connecting the cell chamber to the reagent injection line. The RTchamber was dead-end filled before closing the connection to the reagent injection line. A pulsed temperature RT protocol was carried out by placing the microfluidic device on a flatbed thermocycler (2 min at 16°C, followed by 60 cycles of 30 s at 20°C, 30 s at 42°C, and 1 s at 50°C). RT enzyme was inactivated at 85°C (5 min), and then the device was cooled to 4°C.
The PCR reagent was prepared with 25 μL of 2× TaqMan Universal Master Mix (ABI), 2.5 μL 20× Real-Time miRNA assays (primers and probe, ABI), 5 μL of 1% Tween 20, and 7.5 μL of PCR grade water. The PCR reagent was flowed through the reagent injection channels to flush away the RT reagent. Valves were opened and the PCR reagent was injected to dilute the RT product into the PCR reaction chamber. After completely filling the PCR reaction chamber, the valves closing the PCR chambers were actuated, and the device was transferred to an enclosure for real-time PCR (Prototype version of Biomark™ Instrument, Fluidigm). The real-time PCR enclosure consists of a custom flatbed thermocycler, a xenon arc lamp and filter set, and a CCD imager with optics for fluorescent imaging of the entire device periodically during PCR thermocycling (see description of real-time PCR instrumentation below). PCRs were thermocycled with the following conditions: 10 min at 95°C, followed by 50 cycles of 15 s at 95°C and 1 min at 60°C. Images were acquired at 60°C.
Protocol timing for performing heat lysis and two step RT-qPCR in the microfluidic system
Step Description Time RT-qPCR. Measurements of mRNA transcripts (SP1, GAPDH) were performed using the Cells Direct kit (Invitrogen). Operation of the microfluidic device for chemical lysis and one-step RT-qPCR was similar to the methods described for heat lysis and two-step RT-qPCR with several distinctions. The device was primed and cells were washed with PBS containing 0.5 mg∕mL BSA. Additional RNase inhibitor was omitted as the chemical lysis buffer (10 μL lysis resuspension buffer, 1 μL lysis enhancer solution, Invitrogen, USA) contained RNA stabilizing agents. Cell loading was the same as in the heat lysis and two-step RT-qPCR scenario. Single cells were lysed by injecting a chemical lysis buffer through the cell-capture chamber and filling the 10-nL chamber (used for RT reagent injection in the two-step protocol). The lysis reaction was incubated at room temperature for 10 min, followed by heat inactivation of the lysis reagent by placing the device on a flatbed thermocycler and incubating at 70°C for 10 min. The one-step RT-qPCR mix [1 μL of SuperScript III RT/Platinum Taq Mix, 25 μL of 2× Reaction Mix (with ROX reference dye), 2.5 μL of 20× TaqMan Assay (primers and probes, ABI), 1 μL of 50 mM MgSO 4 , 5.5 μL of H 2 O, and 5 μL of 1% Tween 20] was then combined with the cell lysate into the final 50-nL reaction chamber. The device was transferred to the real-time PCR enclosure for temperature control and imaging of the onestep RT-qPCR (20 min at 50°C for RT, followed by a hot-start at 95°C for 2 min, and 50 cycles of 15 s at 95°C and 30 s at 60°C).
Protocol timing for performing chemical lysis and one step RT-qPCR in the microfluidic system
Step Description Time Flush fluidic bus and reagent injection lines with reagent for lysis 2 min 7
Inject lysis reagent through the cell-capture chamber, dead-end filling the 10-nL chamber 1 min 8
Close reagent injection valve, creating isolated reactors combining the cell-capture chamber and lysis reservoir chamber 30 s 9
Perform lysis at room temperature and heat inactivation of the lysis reagent at 75°C by placing device on flatbed thermocycler 25 min 10
Flush fluidic bus and reagent injection lines with reagent for RT-qPCR 2 min 11
Inject RT-qPCR reagent through combined cell-capture/lysis chamber into 50 nL RT-qPCR chamber.
min 12
Close valve to RT-qPCR chamber. Allow for mixing by diffusion 40 min 13 Load device into BioMark real-time PCR system and focus camera 5 min 14
Run RT-qPCR protocol Digital PCR Experiments. For mRNA digital PCR analysis cells were washed with PBS containing 0.5 mg∕mL BSA, lysed in chemical lysis buffer, reverse transcription was performed in tubes according to the protocol described above, and the resulting cDNA product was loaded into digital PCR arrays. For miRNA studies, cells were lysed in PBS containing 0.5 mg∕mL BSA and 0.5 U∕μL RNase inhibitor. Reverse transcription was performed using miR-NA stem-loop primers (Applied Biosystems) and the High Capacity cDNA Reverse Transcription kit (Applied Biosystems) in 10-μL volumes. Prior to injection into microfluidic digital PCR arrays, RT product was added to the PCR reagent as in the on-chip two-step RT-qPCR protocol described above. Thermal cycling of digital PCR arrays was also performed using the same protocols as described above. PDMS digital PCR arrays consisting of 765 2-nL individual PCR chambers, of similar design to those described in Warren et al. (4), were fabricated by multilayer soft lithography. After thermal cycling, positive chambers were counted and actual molecule numbers were derived based on the binomial distribution.
System for Real-Time PCR. The BioMark™ Reader is a commercially available real-time PCR instrument developed by Fluidigm and designed to run Fluidigm Integrated Fluidic Circuits (IFCs). The prototype version of this system allowed access to the flatbed thermocycler inside the enclosure, permitting the use of custom microfluidic devices in addition to the intended commercial IFCs. Fundamental specifications for data collection include the following: Measuring mRNA in the presence of genomic DNA requires primers designed to specifically target mature mRNA sequences. In many cases, this can be accomplished by designing intron-spanning primers. A specially designed stemloop RT primer system (Applied Biosystems) is used for the specific targeting of mature miRNAs. TaqMan assays for GAPDH (Applied Biosystems, Assay ID Hs99999905_m1) and miRNAs were obtained from Applied Biosystems. For GAPDH, a control experiment omitting the reverse transcriptase was performed off chip, in microliter volumes with bulk cell lysate (at equivalent concentration of a single cell on chip, 10 5 cells∕mL), and showed no amplification after 40 cycles of PCR.
OCT4 ( BHQ-Plus probes with enhanced duplex stabilization (Biosearch Technologies Inc.) were used for SNV detection to allow for shorter sequence lengths and increased specificity. The SNV location for the SP1 locus was selected from table 2 in Shah et al. (5) . Two hundred base pairs flanking this location on the hg18 sequence were used for assay design using Primer3. The resulting primer and probe sequences were as follows (the SNV is underlined):
SP1 Control experiments without reverse transcriptase showed positive amplification. Therefore the measurement of SP1 mutant and wild-type abundance in single cells by RT-qPCR does not discriminate between mature mRNA transcripts and genomic DNA.
Image Analysis. Fluorescence images of the entire device were taken in at least two different colors (one passive reference dye and one or more reporter dyes) after each PCR cycle and were analyzed using custom scripts written in MATLAB (MathWorks) to generate real-time amplification curves. Reaction chambers were segmented from the rest of the image using the first image of the passive reference dye. The image was manually rotated so that all of the reaction chambers were square with the edges of the image. Next, the average image intensities across each row and column were calculated and a threshold was manually set to differentiate bright areas from background. Regions containing both bright rows and bright columns were assigned to the reaction chambers.
All subsequent images were automatically aligned to this initial image by minimizing the absolute distance between the average row and column intensities of the initial image, and the one being analyzed. For each image, the intensities of the reporter and passive dyes were recorded for each reaction chamber. Real-time amplification curves were generated by normalizing the intensity of each reporter dye to that of the passive dye. Linear components were removed from these curves by fitting the equation of a line to the preexponential region and extrapolating and subtracting the result from the entire curve. The threshold for determining CT values was automatically determined as the median normalized fluorescence value at the maximum second derivative of all amplification curves.
mRNA-FISH. Cells grown on LABTEK chambered cover glass were washed with PBS, fixed in 4% formaldehyde for 10 min at room temperature and permeabilized in 70% EtOH at 40°C overnight. The next day cells were rinsed with wash buffer (15% formamide in 2× SSC) and then hybridized with the appropriate dilution of mRNA-FISH probes specific to OCT4 (Table S1) Fluorescent spots corresponding to individual mRNA molecules in each image stack were evaluated manually because automatic thresholding using previously reported algorithms were found to be unreliable. Difficulty in automating this process was attributed to inconsistent signal to noise using reported protocols and may be related to the thickness of hESC cells (approximately 15 μm). In addition, manual intervention was needed to ascertain the boundaries of adjacent cells. To optimize the signal to noise we systematically varied the probe concentration, incubation time, incubation temperature, as well as the formamide concentration in the hybridization buffer solution.
Cell Culture. K562 cells were cultured in DMEM (Gibco) supplemented with 10% FBS (Gibco). Purified RNA was extracted from K562 cells using RNA MiniPrep (Qiagen).
CA1S hESCs (6, 7) were propagated in mTeSR (8) basal medium (STEMCELL Technologies, Inc.), additionally supplemented with antibiotic-antimycotic mix (100 U∕mL penicillin, 100 mg∕mL streptomycin, and 0.25 mg∕mL amphotericin B) (Invitrogen). Upon passaging, hESCs were washed with PBS prior to incubating with TrypLE Express (Invitrogen) at 37°C for 10 min to detach single hESCs from 4-to 8-d-old cultures depending on confluency. TrypLE Express was neutralized with mTeSR supplemented with antibiotic-antimycotic mix and suspensions were then transferred into new tissue culture dishes *http://www.rtprimerdb.org/.
containing a precoated layer of 1∶30 diluted Matrigel (Becton Dickinson) and mTeSR supplemented with antibiotic-antimycotic mix. For differentiation, mTeSR was replaced with DMEM with 10% FBS 1 d after plating cells.
When harvesting hESCs for qRT-PCR, cells were incubated with TrypLE Express (Invitrogen) at 37°C for 20 min in order to produce a more uniform single-cell suspension from 4-to 8-d-old cultures.
Cryovials of primary cells isolated from a lobular breast cancer metastasis were provided by the BC Cancer Agency in accordance with ethical guidelines of the University of British Columbia. To increase viability, cells were transferred to fresh culture medium and incubated for 2 d before analyzing in the microfluidic device. Cell-Capture Measurements. A custom microfluidic device with a linear array of cell trap geometries was fabricated using protocols described above. The device was mounted on an inverted microscope (Leica DM IRE2) and imaged in bright field using a CCD camera (Hamamatsu ORCA-ER). The device was primed with 0.05% BSA (Gibco) in PBS (Gibco). Prior to loading in the device, cells were washed twice in fresh culture media [DMEM (Gibco) supplemented with 10% FBS (Gibco)]. After the final wash cells were resuspended to be at a concentration of 1 million per mL. Input sample viability was measured with the Cedex Automated Cell Counter (Roche Innovatis AG).
To measure the capture efficiency, cells were pumped through the array using a downstream microfluidic peristaltic pump at a rate of approximately 1 nL∕s, and the number of cells that bypassed each trap before a successful trapping event was recorded. These counts were fit using a maximum-likelihood estimator for a geometric distribution with the fitdistr function (MASS package version 7.3-6) in R (version 2.11.1). Efficiencies are reported as the probability of a successful capture for each cell.
To measure cell viability after loading, cells were loaded into the array using pressure driven flow as described above until high trap occupancy was observed. 0.2% trypan blue (Gibco) in PBS was then flowed over the trapped cells. Viability was calculated as the number of unstained cells divided by the total number of cells.
Cell diameter was measured from Cedex images and images of cells trapped in the microfluidic device using ImageJ (version 1.43u). A two-sample t test was used to test the hypothesis that the resulting size distributions were significantly different. The assumption of equal variance was tested using an F test. For optimized cell trap geometries the cell trapping efficiency was improved to 87% by bringing the cup within one cell diameter of the focuser and by including a small bypass shunt through the cup, similar to the cup geometry presented in Skelley et al. (9) .
Mixing by Diffusion. Mixing of solutions by diffusion was characterized in the microfluidic device by loading fluorescently labeled 40 base poly-A oligonucleotides into the 10-nL chambers, and pushing the contents of the chamber into the adjacent 50-nL chambers. Time-lapse imaging was used to measure the evolution of the distribution of fluorescently labeled oligonucleotides in the PCR chambers over time (Fig. S7) . The standard deviation of the pixel intensities in each chamber through time was used as a metric of mixing. The resulting curves of all analyzed chambers (N ¼ 200) were each fit to a decaying exponential using least squares regression to determine the characteristic mixing time constant. This resulted in a mean mixing time of 15.2 AE 1 min.
Using the Stokes-Einstein relation and assuming a random coil we estimate the diffusion constant of a 40 base oligonucleotide to be
where K B T is the thermal energy (4.1 pN·nm), η is the fluid viscosity (approximately 0.001 kg∕m·s), and R h is the coil hydrodynamic radius (10) . The hydrodynamic radius is proportional to the radius of gyration R g , and is given by
where L is the contour length of single stranded DNA (40 bases × 4.3 Å∕base) and p is the persistence length (approximately 40 Å) (10). This yields a diffusion value of approximately 9.0 × 10 −11 m 2 s −1 , which is comparable to the diffusion constant of polymerase, the largest molecule in the PCR mix. Since the template solution constitutes only 1∕5 of the final PCR reaction it must diffuse the longest distance to equilibrate across the chamber. Therefore, the measured diffusion time of 15.2 min represents an upper bound to the time constant for complete mixing of all components. 
